Novo Nordisk rises as Wegovy pill rolls out in Germany
Novo Nordisk rose about 0.5% to $45.545 after rolling out its Wegovy pill in Germany, bringing the oral weight-loss treatment to the EU’s largest pharmaceutical market.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.